Current news and events

Theodossis A. Theodossiou researcher of the year at the Institute for Cancer Research

Theodossiou with Institute head Kjetil Taskén during the ceremony
Theodossiou with Institute head Kjetil Taskén during the ceremony

Theodossis A. Theodossiou – senior researcher and project group leader at Institute for Cancer Research - was awarded the prize researcher-of-the-year 2019 from the leadership at ICR for his oustanding scientific contribution in 2019. The award of 100 000 NOK is financed by Radiumhospitalets legater and is a personal scholarship for stimulating further excellence in research. 

ERC Consolidator Grant of 20 million NOK awarded to Johanna Olweus

Johanna Olweus (photo: UiO)
Johanna Olweus (photo: UiO)

Professor Johanna Olweus - head of the Experimental Immunotherapy Group at the Department of Cancer Immunology - was awarded the Consolidator Grant from the European Research Council (ERC) for her project on immunotherapy “OUTSOURCE: Outsourcing cancer immunity to healthy donors”.

New immune-related breast cancer subtypes described in Nature Communications

First author Xavier Tekpli and senior author Vessela Kristensen
First author Xavier Tekpli and senior author Vessela Kristensen

In a study published December 3rd in Nature Communications, Xavier Tekpli in Vessela Kristensen’s group and their colleagues from the EMIT study report an immune-related breast cancer subtype which identifies patients with poor prognosis and in need of new treatment strategies.

Scientists from the EMIT study, from left to right:
Bjørn Naume, Therese Sørlie, Hege Russnes, Hege
Oma Ohnstad, Elin Borgen and Gry Aarum Geitvik.

 

 

How B cell receptor ligation and T cell help drives chronic pathological B cell expansion

First author Peter Huszthy, second author Ramakrishna Gopalakrishnan and senior author Bjarne Bogen
First author Peter Huszthy, second author Ramakrishna Gopalakrishnan and senior author Bjarne Bogen

B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells." published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) this week, first author Peter Huszthy and researchers from Bjarne Bogen's group at the Department of Immunology demonstrate the importance of B cell receptor (BCR) ligation by antigen for Idiotype-driven T cell-B cell collaboration. Idiotype-driven T cell-B cell collaboration, if made chronic, may lead to the development of systemic autoimmune disease and B cell lymphomas.

Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2019

Award winners at the ceremony
Award winners at the ceremony

In order to stimulate excellent research and draw attention to the hospital's research activity, Oslo University Hospital reward outstanding publications every half-year.

Six research groups were awarded for their excellent papers published during the first half-year of 2019 on November 22nd. Each group received NOK 50.000 for use in further research. The prize winners then gave short presentations of their important findings.

 

Young researcher award to Peter Wold Eide at “Onkologisk Forum”

Dr. Peter Wold Eide, post doc in the Lothe lab received the "Young researcher award" for his scientific accomplishments during the 2019 Onkologisk forum held in Tromsø November 21st-22nd .

The evaluation committee pointed out his competence in cell biology, bioinformatics and pharmacogenomics, and that his research assessing drug sensitivities in combination with genomics in patient derived preclinical models is important for further development of precision oncology. 

Ceremony Friday November 15th:Ragnar Mørk legacy prize 2019 to Karl-Johan Malmberg

Karl-Johan Malmberg with Kjetil Taskén
Karl-Johan Malmberg with Kjetil Taskén

Karl Johan Malmberg from the Department of Cancer Immunology at Institute for Cancer Research has received Dr. Ragnar Mørk's Prize 2019 for his excellent research on natural killer (NK) cells. Malmberg's research has improved our understanding of how NK cells are activated, which opens new possibilities for using NK cells in cancer immunotherapy. Malmberg is currently exploring this concept in ongoing clinical trials.

Vessela Kristensen appointed Head of Research at the Department of Medical Genetics.

Vessela N. Kristensen
Vessela N. Kristensen

Vessela Kristensen is appointed Head of Research at the Section for Research and Development at the Department of Medical Genetics. 
During her 23 years at the Institute for Cancer research (1996-2019), she has lead multiple projects and attracted external funding for more than 40 mill. NOK leading 9 PhD students as a main supervisor. In the last 13 years (20006 - 2019) she has been professor I at Institute for clinical medicine, Campus Ahus, where she supervised additional 6 PhD students and generated external funding for 21 million NOK. "Now it is time for something new" says Vessela Kristensen.


More news from the archive